Brightening Series

Azelaic Acid Technical Guide: Concentration Limits, Solubility & Grade Selection | Onerchem

Azelaic Acid Technical Guide: Concentration Limits, Solubility & Grade Selection | Onerchem
Technical Guide

Azelaic Acid Technical Guide: Concentration Limits, Solubility Problem & Grade Selection for B2B Buyers

Most azelaic acid content focuses on concentration — 10%, 15%, 20%. The more important question for formulators and OEM buyers is rarely asked: how are you suspending it? Azelaic acid dissolves in water at only 0.24%. Every product above 1% is a suspension system. Particle size, milling grade, and suspension stability determine product performance more than concentration alone.

Author: Yang Ruosong, Onerchem Published: May 2026 Reading time: ~11 min Series: Brightening Series

What Azelaic Acid Is

Azelaic acid (nonanedioic acid, CAS 123-99-9) is a saturated, nine-carbon dicarboxylic acid. It occurs naturally in grains — wheat, rye, barley — and is also produced endogenously on human skin by Malassezia furfur, a yeast species that is part of the normal skin microbiome. ✅ Verified — CosmeticsScience.net; PubMed review

For commercial cosmetic and pharmaceutical use, azelaic acid is produced synthetically by ozonolysis of oleic acid (from sunflower or other vegetable oils), followed by purification and micronisation. The synthesis route makes it fully vegetarian and free of animal-derived materials.

Azelaic acid is a white, crystalline powder with the following physical properties relevant to formulation:

  • Molecular weight: 188.22 g/mol
  • Melting point: 106–111°C
  • Water solubility: ~0.24% w/w at 20°C — practically insoluble at room temperature ✅ Verified — US Patent 5925679; Azeco technical data
  • Solubility in oils: Little to none — does not dissolve in typical cosmetic lipid phases
  • pKa: 4.55 (pKa1) — behaves as a weak acid in formulation systems

These physical properties make azelaic acid genuinely challenging to formulate at effective concentrations — a fact that is underappreciated in most supplier documentation and product briefs.

Four Mechanisms of Action

Azelaic acid is multi-functional. Its clinical applications span acne, rosacea, hyperpigmentation, and post-inflammatory hyperpigmentation (PIH), because it operates through four distinct but complementary mechanisms simultaneously.

Mechanism Target Clinical Application Evidence Level
Tyrosinase inhibition Melanin synthesis pathway — blocks conversion of tyrosine to DOPA Hyperpigmentation, melasma, PIH, brightening ✅ Multiple RCTs; comparable to 4% hydroquinone at 20% concentration
Antimicrobial Cutibacterium acnes (formerly P. acnes) and Staphylococcus epidermidis — disrupts bacterial protein synthesis Acne vulgaris, comedolytic ✅ FDA-approved at 20% for acne
Anti-inflammatory Reactive oxygen species (ROS) scavenging; inhibits neutrophil superoxide generation Rosacea, inflammatory acne, reactive skin ✅ FDA-approved at 15% for rosacea
Keratolytic Normalises keratinisation — reduces follicular hyperkeratosis Acne, skin texture improvement, pore appearance ⚠ Mechanism established; clinical evidence primarily at ≥10%
📋 For B2B Product Positioning

Azelaic acid's multi-mechanism profile means it can be positioned in brightening, acne, rosacea, and sensitive skin product lines without reformulation. The same raw material at the same concentration serves different marketing angles depending on the target consumer and claims framework. This versatility makes it unusually efficient as a core active for OEM product development.

Concentration, Regulation & the Cosmetic/Pharmaceutical Boundary

Azelaic acid's regulatory status is concentration-dependent, and the boundary between cosmetic and pharmaceutical classification varies by market. This is the first decision a B2B buyer or product developer must make — it determines not just the formulation target but the entire regulatory pathway.

Market Cosmetic (no prescription) OTC / Quasi-drug Prescription required
EU ≤10% — freely permitted as cosmetic 10–15% — grey zone, dermo-cosmetic claims ≥15% — medicinal product, requires authorisation
USA (FDA) <15% — cosmetic use, no prescription No distinct OTC category for azelaic acid 15% gel (rosacea) and 20% cream (acne) — FDA-approved drugs, prescription only
UK ≤10% — cosmetic 10–14% — dermo-cosmetic boundary ≥15% — prescription medicine (Finacea®, Skinoren®)
China (NMPA) Listed as permitted cosmetic ingredient; concentration guidance follows EU broadly Whitening claims require special cosmetic registration Pharmaceutical applications require drug registration
South Korea (MFDS) Permitted in cosmetics Functional cosmetic registration for whitening or acne claims at higher concentrations Pharmaceutical at therapeutic concentrations
⚠ Practical Rule for OEM Buyers

If your customers sell into the EU or UK, formulate to ≤10% azelaic acid for cosmetic status without complexity. Products at 10–14% occupy a regulatory grey zone that requires careful claims management. Any product at ≥15% is a pharmaceutical in EU/UK and requires medicinal product authorisation — this is not a cosmetic ingredient procurement question at that point, it is a pharmaceutical development question. The raw material is the same; the regulatory pathway is entirely different.

For most cosmetic OEM applications, the practical working range is 5–10%, which delivers meaningful brightening and skin texture improvement while maintaining cosmetic regulatory status in all major markets. Studies confirm that 10% azelaic acid achieves noticeable tone improvement within 8–12 weeks of daily use. ✅ Verified — CosmeticsScience.net review of clinical data

The Solubility Problem: Why Every Azelaic Acid Product Above 1% Is a Suspension

This is the most important technical fact about azelaic acid formulation, and it is the one most consistently absent from supplier product pages and generic technical guides.

Azelaic acid dissolves in water at approximately 0.24% w/w at room temperature. ✅ Verified — US Patent 5925679; Azeco technical documentation It has negligible solubility in cosmetic oils. It is sparingly soluble in alcohols, but the concentrations of alcohol required to dissolve cosmetically relevant quantities of azelaic acid are too high for leave-on skincare formulations.

A 10% azelaic acid product contains approximately 42 times more azelaic acid than water can dissolve at room temperature. The ingredient is not in solution — it is suspended as solid particles throughout the formulation.

— The fundamental formulation reality of every azelaic acid product at cosmetic use concentrations

This has direct implications for product performance, stability, and sensory experience:

  • Skin penetration is surface-area dependent: Azelaic acid must dissolve from the particle surface into the skin before it can be absorbed. Smaller particles = more surface area = faster dissolution rate = better skin penetration at equal weight concentration
  • Gritty texture: Larger particles produce a sandy or gritty feel in formulations. This is the most common consumer complaint about azelaic acid products and is a direct consequence of insufficient milling
  • Sedimentation: In suspension systems, particles settle over time unless stabilised by rheology modifiers. Poor suspension stability creates product separation and inconsistent dosing
  • Appearance: Well-milled azelaic acid creates smooth, opaque white formulations. Poorly milled material creates visible white streaks or grainy texture even in cream bases

How Solubility Can Be Enhanced

Several approaches are used commercially to increase effective azelaic acid incorporation:

  • Alkaline neutralisation to azelate salt: At pH >5.5, azelaic acid partially ionises to its azelate anion, which is more water-soluble than the free acid. Partial neutralisation with potassium hydroxide or triethanolamine improves solubility while maintaining efficacy. Used in gel formulations. ✅ Verified — GrandIngredients formulation guide; Azeco data
  • Polar solvent addition: Propylene glycol, ethoxydiglycol, ethoxytriglycol, and pentylene glycol all improve azelaic acid solubility significantly. These are the standard approach for suspension-type serums and creams
  • Microemulsion systems: PubMed research shows microemulsion carriers with droplet sizes of 5–150 nm significantly increase follicular delivery compared to standard suspensions ✅ Verified — PMC7191225
  • Nanosuspension: Commercial-scale nanosuspensions (particle size 326–541 nm) have been demonstrated to achieve 20% drug loading with good stability ✅ Verified — PMC12030390 (Pharmaceutics, 2025)

For standard OEM cosmetic applications, the practical approach is: micronised azelaic acid (D90 ≤10μm) + polar solvent addition (propylene glycol or ethoxydiglycol at 5–10%) + rheology modifier for suspension stability.

Particle Size: The Specification Most COAs Don't Include But Should

Particle size is the single most important quality parameter for azelaic acid beyond purity — yet the majority of supplier COAs do not include it. This is a critical gap for OEM buyers.

The commercially recognised benchmark for cosmetic-grade azelaic acid is a D90 particle size of ≤10 μm — meaning 90% of particles are below 10 micrometres. This is the specification used by pharmaceutical-grade suppliers for cosmetic applications. ✅ Verified — BASF Dermaz99® product specification (D90 ≤10μm); PMC12030390

Particle Size (D90) Skin Feel Penetration Efficiency Suspension Stability Application
<5 μm Smooth, silky High Good Premium serums, high-performance formulas
5–10 μm Smooth Good Good Standard cosmetic grade — industry benchmark
10–30 μm Slightly rough Moderate Requires stabiliser Acceptable for cream formats with high emollient content
>30 μm Gritty / sandy Low Poor without heavy thickener Not suitable for cosmetic skin contact applications
❌ Common Sourcing Error

Accepting an azelaic acid COA that shows "≥99% purity" without particle size data, then experiencing gritty texture or poor performance in the finished product. The purity was correct — the problem was particle size. A ≥99% purity figure tells you the compound is present and pure; it tells you nothing about the physical form that determines formulation behaviour. Always request D90 particle size data alongside purity.

For OEM buyers, the practical procurement requirement is: cosmetic-grade azelaic acid with ≥99% purity by HPLC and D90 particle size ≤10μm, with particle size data declared on the batch COA.

Formulation Parameters

pH Range

Azelaic acid performs best in mildly acidic systems at pH 4.5–5.5. This range preserves antimicrobial efficacy and skin compatibility. ✅ Verified — GrandIngredients formulation guide Below pH 4.0, increased free acid concentration can cause irritation. Above pH 6.0, solubility improves due to ionisation but antimicrobial and keratolytic properties decrease as the free acid converts to azelate salt. For brightening-focused formulations where antimicrobial activity is secondary, slightly higher pH (5.5–6.5) can improve skin compatibility.

⚠ Niacinamide Combination Note

If combining azelaic acid with niacinamide in the same formulation, target pH ≥5.5. At lower pH with heat, niacinamide can partially convert to nicotinic acid (niacin), which causes skin flushing. Azelaic acid and niacinamide are mechanistically complementary for brightening — both are tyrosinase inhibitors — and the combination is clinically well-supported, but pH management is essential. See the Niacinamide Supplier Guide for detailed niacinamide formulation parameters.

Addition Protocol

Azelaic acid should be added to the water phase post-emulsification, during cool-down at approximately 40°C or below. Adding to the hot phase causes unnecessary thermal exposure and does not improve dispersion because it remains as a suspension regardless of temperature in standard cosmetic systems. Pre-wet the powder with a small amount of glycol solvent before adding to the bulk to improve dispersion and minimise agglomeration.

Suspension Stabilisation

For formulations above 3% azelaic acid, a suspension stabiliser is required to prevent particle sedimentation during shelf life. Effective options include:

  • Carbomer or carbopol (0.2–0.5%) — forms a polymer network that suspends particles through yield stress
  • Xanthan gum (0.2–0.4%) — biopolymer suspending agent, compatible across a wide pH range
  • HPMC (0.5–1.0%) — useful in gel formulations; also stabilises nanosuspensions ✅ Verified — PMC12030390
  • Acrylate polymers — provide both thickening and suspension stability in water-based serums

Packaging Considerations

Azelaic acid suspensions require packaging that minimises particle settling and maintains consistent dosing per application:

  • Pump dispensers: Preferred — maintains suspension homogeneity through the pump mechanism
  • Airless bottles: Best option for high-concentration formulations — prevents oxidation and maintains dosing consistency
  • Open-mouth jars: Not recommended for suspension formulations — particle settling creates inconsistent application and potential hygiene issues

Compatibility

Azelaic acid is broadly compatible with most cosmetic actives at typical use concentrations. Well-documented synergistic combinations include:

  • Niacinamide — complementary tyrosinase inhibition + melanin transfer inhibition; manage pH as noted above
  • Alpha-arbutin — additive brightening from different pathway points
  • Tranexamic acid — upstream MITF suppression complements azelaic acid's tyrosinase inhibition for PIH
  • Panthenol — barrier support reduces the mild transient irritation some users experience at higher azelaic acid concentrations

Avoid combining with high concentrations of strong anionic polymers without compatibility testing, and avoid using in anhydrous/oil-only systems where azelaic acid cannot disperse.

COA Verification Checklist

📋 Azelaic Acid COA — Minimum Acceptance Criteria
✓Assay by HPLC: ≥99.0% — HPLC required for identity confirmation; UV-Vis alone is insufficient
✓Particle size (D90): ≤10 μm — this is the most important parameter for formulation performance and must be declared on the batch COA. If absent, request it explicitly before ordering
✓CAS number: 123-99-9 — verify against the batch COA
✓Appearance: White crystalline powder — any discoloration (yellow, brown) indicates impurity or degradation
✓Melting point: 106–111°C — deviation indicates impurity or wrong compound identity
✓Heavy metals by ICP: ≤10 ppm total; arsenic ≤2 ppm; lead ≤2 ppm
✓Loss on drying: ≤0.5% — azelaic acid is stable but elevated moisture suggests storage failure
✓Residue on ignition: ≤0.1%
✓Related substances / dibasic acid profile: C8 acid (suberic acid) ≤1.5%; C10 acid (sebacic acid) ≤1.0% — these are synthesis-related impurities from oleic acid ozonolysis. Premium grades specify these individually
⚠Particle size absent from COA: Request explicitly before committing to bulk order — do not assume D90 ≤10μm without documented data
✗Assay by UV-Vis only: Cannot confirm identity or distinguish azelaic acid from structurally similar dicarboxylic acids — reject as insufficient for cosmetic grade procurement
✗No related substances data: For pharmaceutical-adjacent concentrations (≥10%), absence of dibasic acid impurity data is a documentation gap — request before use in claims-bearing products

Onerchem's Azelaic Acid

Onerchem supplies cosmetic-grade azelaic acid for bulk OEM manufacturing. Available in standard cosmetic grade (≥99% HPLC, D90 ≤10μm) suitable for brightening serums, acne treatment products, rosacea-targeted formulations, and multi-functional skin tone correction products.

✅ Standard Documentation Per Batch

Batch-specific COA: HPLC assay ≥99%, particle size D90 ≤10μm, melting point, heavy metals by ICP, loss on drying, dibasic acid impurity profile · MSDS · MOQ 50kg · In-stock orders dispatch 3–7 days · Sample available before bulk order commitment

For formulations combining azelaic acid with complementary brightening actives, Onerchem also supplies niacinamide, alpha-arbutin, and tranexamic acid for multi-active brightening system development.

Request Azelaic Acid Samples or Bulk Pricing

≥99% HPLC, D90 ≤10μm. Particle size data on batch COA. MOQ 50kg.

Request Pricing →

Frequently Asked Questions

For OTC cosmetic brightening with EU/UK cosmetic regulatory status, formulate at 5–10% azelaic acid. Clinical studies confirm meaningful brightening and PIH improvement within 8–12 weeks at 10%. The lower end of this range (5–7%) is appropriate for sensitive skin positioning and reduces the mild transient irritation some users experience at higher concentrations. Combining 5% azelaic acid with niacinamide (3–5%) and alpha-arbutin (0.5–1%) gives a three-mechanism brightening system that typically outperforms higher single-active concentrations while maintaining excellent skin compatibility.
Gritty texture in azelaic acid formulations is caused by insufficient particle size reduction in the raw material. Azelaic acid cannot dissolve at cosmetic use concentrations — it exists as suspended solid particles throughout the formulation. Particles above approximately 20–30 μm are perceptible on the skin as grittiness. The solution is to use a properly micronised grade with D90 ≤10μm, and to verify particle size on the supplier's COA before procurement. If you are experiencing this problem with an existing batch, the raw material specification is likely the issue, not the formulation process.
Yes, with pH management. Both azelaic acid and L-ascorbic acid require acidic pH for stability and efficacy (azelaic acid pH 4.5–5.5; ascorbic acid typically pH 2.5–3.5). A formulation targeting both can work at pH 3.5–4.5, where ascorbic acid is stable and azelaic acid remains functional. However, note that azelaic acid's antimicrobial efficacy decreases somewhat below pH 4.5, and very low pH systems may reduce skin comfort. A more practical combination approach is to use azelaic acid in a separate product step from high-dose L-ascorbic acid, or to substitute a more pH-flexible vitamin C derivative (such as 3-O-EAA or AA2G) if combining in a single formulation.
Azelaic acid has a well-established safety profile and is generally considered one of the safer topical actives for use during pregnancy. Systemic absorption is low — studies show less than 4% of applied dose is absorbed systemically, and the absorbed portion is metabolised through normal fatty acid pathways. ✅ Verified — CosmeticsScience.net It is non-mutagenic and non-teratogenic in available data. For this reason, it is frequently cited by dermatologists as a preferred alternative to retinoids and hydroquinone in pregnant patients. As a B2B supplier, we provide technical data; final product safety assessment and claims should be conducted by the finished product manufacturer's regulatory team.
The active compound is identical — both are azelaic acid, CAS 123-99-9. The differences are in specification stringency, documentation requirements, and manufacturing standards. Pharmaceutical-grade material is manufactured under GMP conditions compliant with ICH Q7 guidelines, with stricter limits on related substances (dibasic acid impurities), tighter particle size specifications, and more extensive lot-to-lot testing documentation. Cosmetic-grade material at ≥99% HPLC purity with D90 ≤10μm meets the requirements for all cosmetic applications including high-concentration products up to the cosmetic/pharmaceutical boundary. If you are developing a pharmaceutical product (15–20% azelaic acid as a medicinal product), pharmaceutical-grade material with full API documentation is required. For cosmetic formulations at ≤10%, high-quality cosmetic-grade material is appropriate and significantly more cost-effective.
YR
Yang Ruosong
Cosmetic Ingredient Sourcing, Onerchem

Yang Ruosong oversees ingredient sourcing and technical documentation at Onerchem. Onerchem supplies bulk cosmetic ingredients to OEM manufacturers and cosmetic brands globally. MOQ 50kg. See the Knowledge Hub or request bulk pricing.

Leave a Reply

Your email address will not be published. Required fields are marked *